Were the MICROCHIP TECHNOLOGY (MCHP) CFO’s share sales under a Rule 10b5-1 plan?

Yes. A footnote states the sales were effected under a Rule 10b5-1 trading plan adopted by the reporting person. Such plans pre-schedule trades, meaning the timing is typically routine rather than a discretionary market-timing decision.

Microchip (NASDAQ: MCHP) CFO trust sells 3,667 shares

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

MICROCHIP TECHNOLOGY INC Senior VP and CFO James Eric Bjornholt, through a trust, reported two open-market sales of Microchip common stock. The trust sold 3,667 shares in total, with 334 shares sold at about $93.11 per share and 3,333 shares sold at $90.64 per share.

These transactions were executed as indirect holdings "held by Trust" and were carried out under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person. Such plans automate trading under preset instructions, making the timing of these sales more routine.

Insider Trade Summary 10b5-1

Net Seller: 3,667 shares ($333,203)

Net Sell 2 txns

Insider Bjornholt James Eric

Role SENIOR VP AND CFO

Sold 3,667 shs ($333K)

Type	Security	Shares	Price	Value
Sale	Common Stock	3,333	$90.64	$302K
Sale	Common Stock	334	$93.1148	$31K

Holdings After Transaction: Common Stock — 28,907 shares (Indirect, Shares held Indirectly, by Trust.)

Footnotes (1)

[object Object]

Form 4 Insider Transactions: What Each Field Means →

05/26/2026 - 05:03 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bjornholt James Eric

(Last)

(First)

(Middle)

C/O MICROCHIP TECHNOLOGY INCORPORATED

2355 WEST CHANDLER BOULEVARD

(Street)

CHANDLER

ARIZONA

85224-6199

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MICROCHIP TECHNOLOGY INC [ MCHP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SENIOR VP AND CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/22/2026		S⁽¹⁾		3,333	D	$90.64	28,907	I	Shares held Indirectly, by Trust.
Common Stock	05/22/2026		S		334	D	$93.1148	28,573	I	Shares held Indirectly, by Trust.

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sale(s) reported in this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2025.

Remarks:

	Deborah L. Wussler, as Attorney-in-Fact	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did MICROCHIP TECHNOLOGY (MCHP) report for its CFO?

MICROCHIP TECHNOLOGY reported that Senior VP and CFO James Eric Bjornholt, through a trust, sold 3,667 shares of common stock. The Form 4 shows two open-market sales executed on May 22, 2026, reflecting indirect holdings held by a trust.

How many MICROCHIP TECHNOLOGY (MCHP) shares were sold in this Form 4?

The filing shows total sales of 3,667 MICROCHIP TECHNOLOGY common shares. One trade covered 334 shares at about $93.11 per share, and another trade covered 3,333 shares at $90.64 per share, all reported as indirect trust-held shares.

At what prices were the MICROCHIP TECHNOLOGY (MCHP) shares sold in this insider trade?

The reported open-market sales occurred at prices near $90–$93 per share. Specifically, 334 shares were sold at $93.1148 per share and 3,333 shares at $90.6400 per share, according to the Form 4 transaction details.

Are the MICROCHIP TECHNOLOGY (MCHP) shares sold held directly by the CFO?

No, the Form 4 classifies the holdings as indirect, noting they are “Shares held Indirectly, by Trust.” This means the transactions involve a trust associated with the reporting person rather than directly registered personal holdings.